No real reason we should be yet. Lots of biotechs and BP companies have drugs that appear useful against cancer in early stages. Too many for anyone to keep up with. Once things get more solidified, THEN we might show up some more radar screens. "Don't tell me about the pain, just show me the baby" kind of approach. Makes sense.